CHESTGuidelines & Topic CollectionsManaging Severe Pneumonia in the ICU: Addressing Drug-Resistant HABP and VABP

Managing Severe Pneumonia in the ICU: Addressing Drug-Resistant HABP and VABP

This education is best experienced on a mobile device. Scan the QR code with your phone or tablet to tap through the module.

QR code

Managing Severe Pneumonia in the ICU
ACCESS NOW »

Follow an evolving ICU patient case and make real-world decisions in the management of severe hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP). This concise, mobile-friendly learning experience combines interactive clinical decision points with expert faculty insights to help you recognize early clinical clues and resistance risks, select appropriate treatment strategies, and use diagnostic and local resistance data to optimize therapy. Explore additional resources along the way to take your learning further.

Learning Objectives

  • Recognize early signs of HABP/VABP in patients who are critically ill.
  • Identify risk factors for multidrug-resistant pathogens, including nonfermenters and carbapenem-resistant Acinetobacter baumannii.
  • Apply evidence-based treatment strategies for HABP/VABP caused by nonfermenters.
  • Use local data and diagnostics to optimize therapy and improve outcomes.

This non-CME credit education is brought to you by CHEST and sponsored by Innoviva Specialty Therapeutics, Inc.

Casey Cable, MD, MSc, FCCP

Pulmonary and Critical Care
Virginia Lung
Mechanicsville, VA

Christian Sandrock, MD, MPH, FCCP

Interim Chief Quality Officer
Associate Chief Medical Officer
Professor of Medicine
UC Davis Health
Sacramento, CA

Advertisement

Close

Advertisement